Table 3 Linear mixed model for dynamic IL-6 levels with corticorsteroids use (with or without) in patients with COVID-19.
Estimate | P | |
|---|---|---|
Without corticosteroids (n = 34) | Ref | |
With corticosteroids (n = 31) | − 9.66 | 0.0215 |
Mild type (n = 10) | Ref | |
General type (n = 32) | 7.78 | 0.1247 |
Severe type (n = 8) | 14.90 | 0.0385 |
Critical type (n = 15) | 25.35 | 0.0005 |
Mild type (n = 10) | − 7.78 | 0.1247 |
General type (n = 32) | Ref | |
Severe type (n = 8) | 7.12 | 0.1574 |
Critical type (n = 15) | 17.58 | 0.0006 |
Mild type (n = 10) | − 14.90 | 0.0385 |
General type (n = 32) | − 7.12 | 0.1574 |
Severe type (n = 8) | Ref | |
Critical type (n = 15) | 10.46 | 0.0195 |
Mild type (n = 10) | − 25.35 | 0.0005 |
General type (n = 32) | − 17.58 | 0.0006 |
Severe type (n = 8) | − 10.46 | 0.0195 |
Critical type (n = 15) | Ref |
